108 related articles for article (PubMed ID: 22462745)
1. Company profile: Sequenom, Inc.
Cantor CR
Pharmacogenomics; 2012 Apr; 13(5):529-31. PubMed ID: 22462745
[TBL] [Abstract][Full Text] [Related]
2. Company Profile: AKESOgen, Inc.
Bouzyk M; Boisjoli R
Pharmacogenomics; 2012 Jul; 13(10):1115-8. PubMed ID: 22909201
[TBL] [Abstract][Full Text] [Related]
3. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
4. [Potential and perspective of genetic testing in Renaissance of laboratory medicine].
Nobori T
Rinsho Byori; 2013 Aug; 61(8):693-9. PubMed ID: 24218766
[TBL] [Abstract][Full Text] [Related]
5. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in the era of personalized medicine - a multiplexed SNP assay using capillary electrophoresis for assessing drug metabolism capacity.
Rai AJ; Yee J; Fleisher M
Scand J Clin Lab Invest Suppl; 2010; 242():15-8. PubMed ID: 20515270
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and oncology: the path forward to a learning health system.
Yu PP; Hoffman MA; Hayes DF
Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
[No Abstract] [Full Text] [Related]
8. Targeted medications. New focus on companion tests.
Reinke T
Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
[No Abstract] [Full Text] [Related]
9. Select biomarkers for tumors of the gastrointestinal tract: present and future.
Bartley AN; Hamilton SR
Arch Pathol Lab Med; 2015 Apr; 139(4):457-68. PubMed ID: 25333834
[TBL] [Abstract][Full Text] [Related]
10. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
Ku CS; Roukos DH
Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
[No Abstract] [Full Text] [Related]
11. Company profile: PGXIS Ltd.
McCarthy A
Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
[TBL] [Abstract][Full Text] [Related]
12. [Personalized medicine 2011].
Blum HE
Dtsch Med Wochenschr; 2011 Mar; 136(10):459-60. PubMed ID: 21365521
[TBL] [Abstract][Full Text] [Related]
13. Genetic diagnostics in inflammatory dermatoses--from insights into pathophysiology to individualized patient management.
Reich K; Blödorn-Schlicht N; Falk TM
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():59-67. PubMed ID: 23721645
[No Abstract] [Full Text] [Related]
14. Role of genomics on the path to personalized medicine.
Tremblay J; Hamet P
Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
[TBL] [Abstract][Full Text] [Related]
15. Genomics: gearing up for the laboratory of the future.
Glorikian H
MLO Med Lab Obs; 2014 Feb; 46(2):8, 11. PubMed ID: 24672844
[No Abstract] [Full Text] [Related]
16. Implementation of pharmacogenetics in clinical practice is challenging.
van Schie RM; de Boer A; Maitland-van der Zee AH
Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
[No Abstract] [Full Text] [Related]
17. Phenocopy and phenoconversion: do they complicate association studies?
Shah RR; Smith RL
Pharmacogenomics; 2012 Jul; 13(9):981-4. PubMed ID: 22838943
[No Abstract] [Full Text] [Related]
18. Prospects of personalized medicine in cardiovascular diseases.
Lenfant C
Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
[TBL] [Abstract][Full Text] [Related]
19. The right roadmap for personalized tests.
Bourzac K
Cancer Discov; 2012 Jun; 2(6):478. PubMed ID: 22684442
[No Abstract] [Full Text] [Related]
20. Experts foresee huge growth in genetic medicine.
Watts G
BMJ; 2011 Oct; 343():d6344. PubMed ID: 21968128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
